Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

Historyis the author of the best stories every told, and it is also the author of some truly revolting and dangerously flawed ...

The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to ...